Терапія з використанням моноклональних антитіл (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Терапія з використанням моноклональних антитіл" in Ukrainian language version.

refsWebsite

Global rank Ukrainian rank

9nih.gov

4^th place

5^th place

6doi.org

2^nd place

4^th place

2web.archive.org

1^st place

2harvard.edu

18^th place

74^th place

1zenodo.org

621^st place

1,216^th place

1archive.org

6^th place

archive.org

Baxter, David (December 2007). Active and passive immunity, vaccine types, excipients and licensing. Occupational Medicine. 57 (8): 552—6. doi:10.1093/occmed/kqm110. PMID 18045976.

doi.org

Waldmann TA (March 2003). Immunotherapy: past, present and future. Nature Medicine. 9 (3): 269—77. doi:10.1038/nm0303-269. PMID 12612576. Архів оригіналу за 13 квітня 2021. Процитовано 5 грудня 2019.
Sharma P, Allison JP (April 2015). The future of immune checkpoint therapy. Science. 348 (6230): 56—61. Bibcode:2015Sci...348...56S. doi:10.1126/science.aaa8172. PMID 25838373.
Olinger GG, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, Pauly M, Whaley KJ, Lear CM, Biggins JE, Scully C, Hensley L, Zeitlin L (October 2012). Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proceedings of the National Academy of Sciences of the United States of America. 109 (44): 18030—5. Bibcode:2012PNAS..10918030O. doi:10.1073/pnas.1213709109. PMC 3497800. PMID 23071322.
Baxter, David (December 2007). Active and passive immunity, vaccine types, excipients and licensing. Occupational Medicine. 57 (8): 552—6. doi:10.1093/occmed/kqm110. PMID 18045976.
Francis RJ, Sharma SK, Springer C, Green AJ, Hope-Stone LD, Sena L, Martin J, Adamson KL, Robbins A, Gumbrell L, O'Malley D, Tsiompanou E, Shahbakhti H, Webley S, Hochhauser D, Hilson AJ, Blakey D, Begent RH (September 2002). A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. British Journal of Cancer. 87 (6): 600—7. doi:10.1038/sj.bjc.6600517. PMC 2364249. PMID 12237768.
Krauss WC, Park JW, Kirpotin DB, Hong K, Benz CC (2000). Emerging antibody-based HER2 (ErbB-2/neu) therapeutics. Breast Disease. 11: 113—24. doi:10.3233/bd-1999-11110. PMID 15687597.

harvard.edu

ui.adsabs.harvard.edu

Sharma P, Allison JP (April 2015). The future of immune checkpoint therapy. Science. 348 (6230): 56—61. Bibcode:2015Sci...348...56S. doi:10.1126/science.aaa8172. PMID 25838373.
Olinger GG, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, Pauly M, Whaley KJ, Lear CM, Biggins JE, Scully C, Hensley L, Zeitlin L (October 2012). Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proceedings of the National Academy of Sciences of the United States of America. 109 (44): 18030—5. Bibcode:2012PNAS..10918030O. doi:10.1073/pnas.1213709109. PMC 3497800. PMID 23071322.

nih.gov

pubmed.ncbi.nlm.nih.gov

Waldmann TA (March 2003). Immunotherapy: past, present and future. Nature Medicine. 9 (3): 269—77. doi:10.1038/nm0303-269. PMID 12612576. Архів оригіналу за 13 квітня 2021. Процитовано 5 грудня 2019.
Sharma P, Allison JP (April 2015). The future of immune checkpoint therapy. Science. 348 (6230): 56—61. Bibcode:2015Sci...348...56S. doi:10.1126/science.aaa8172. PMID 25838373.
Olinger GG, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, Pauly M, Whaley KJ, Lear CM, Biggins JE, Scully C, Hensley L, Zeitlin L (October 2012). Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proceedings of the National Academy of Sciences of the United States of America. 109 (44): 18030—5. Bibcode:2012PNAS..10918030O. doi:10.1073/pnas.1213709109. PMC 3497800. PMID 23071322.
Baxter, David (December 2007). Active and passive immunity, vaccine types, excipients and licensing. Occupational Medicine. 57 (8): 552—6. doi:10.1093/occmed/kqm110. PMID 18045976.
Francis RJ, Sharma SK, Springer C, Green AJ, Hope-Stone LD, Sena L, Martin J, Adamson KL, Robbins A, Gumbrell L, O'Malley D, Tsiompanou E, Shahbakhti H, Webley S, Hochhauser D, Hilson AJ, Blakey D, Begent RH (September 2002). A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. British Journal of Cancer. 87 (6): 600—7. doi:10.1038/sj.bjc.6600517. PMC 2364249. PMID 12237768.
Krauss WC, Park JW, Kirpotin DB, Hong K, Benz CC (2000). Emerging antibody-based HER2 (ErbB-2/neu) therapeutics. Breast Disease. 11: 113—24. doi:10.3233/bd-1999-11110. PMID 15687597.

ncbi.nlm.nih.gov

Olinger GG, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, Pauly M, Whaley KJ, Lear CM, Biggins JE, Scully C, Hensley L, Zeitlin L (October 2012). Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proceedings of the National Academy of Sciences of the United States of America. 109 (44): 18030—5. Bibcode:2012PNAS..10918030O. doi:10.1073/pnas.1213709109. PMC 3497800. PMID 23071322.
Janeway, Charles; Paul Travers; Mark Walport; Mark Shlomchik (2001). Immunobiology; Fifth Edition. New York and London: Garland Science. ISBN 978-0-8153-4101-7. Архів оригіналу за 28 червня 2009. Процитовано 5 грудня 2019.
Francis RJ, Sharma SK, Springer C, Green AJ, Hope-Stone LD, Sena L, Martin J, Adamson KL, Robbins A, Gumbrell L, O'Malley D, Tsiompanou E, Shahbakhti H, Webley S, Hochhauser D, Hilson AJ, Blakey D, Begent RH (September 2002). A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. British Journal of Cancer. 87 (6): 600—7. doi:10.1038/sj.bjc.6600517. PMC 2364249. PMID 12237768.

web.archive.org

Waldmann TA (March 2003). Immunotherapy: past, present and future. Nature Medicine. 9 (3): 269—77. doi:10.1038/nm0303-269. PMID 12612576. Архів оригіналу за 13 квітня 2021. Процитовано 5 грудня 2019.
Janeway, Charles; Paul Travers; Mark Walport; Mark Shlomchik (2001). Immunobiology; Fifth Edition. New York and London: Garland Science. ISBN 978-0-8153-4101-7. Архів оригіналу за 28 червня 2009. Процитовано 5 грудня 2019.

zenodo.org

Waldmann TA (March 2003). Immunotherapy: past, present and future. Nature Medicine. 9 (3): 269—77. doi:10.1038/nm0303-269. PMID 12612576. Архів оригіналу за 13 квітня 2021. Процитовано 5 грудня 2019.